Suppr超能文献

用于癫痫药物重定位研究的具有实验性癫痫疗效的可处方药物 (PDE3) 数据库。

The prescribable drugs with efficacy in experimental epilepsies (PDE3) database for drug repurposing research in epilepsy.

机构信息

School of Medicine, University of Liverpool, Liverpool, UK.

Independent researcher, London, UK.

出版信息

Epilepsia. 2018 Feb;59(2):492-501. doi: 10.1111/epi.13994. Epub 2018 Jan 17.

Abstract

OBJECTIVE

Current antiepileptic drugs (AEDs) have several shortcomings. For example, they fail to control seizures in 30% of patients. Hence, there is a need to identify new AEDs. Drug repurposing is the discovery of new indications for approved drugs. This drug "recycling" offers the potential of significant savings in the time and cost of drug development. Many drugs licensed for other indications exhibit antiepileptic efficacy in animal models. Our aim was to create a database of "prescribable" drugs, approved for other conditions, with published evidence of efficacy in animal models of epilepsy, and to collate data that would assist in choosing the most promising candidates for drug repurposing.

METHODS

The database was created by the following: (1) computational literature-mining using novel software that identifies Medline abstracts containing the name of a prescribable drug, a rodent model of epilepsy, and a phrase indicating seizure reduction; then (2) crowdsourced manual curation of the identified abstracts.

RESULTS

The final database includes 173 drugs and 500 abstracts. It is made freely available at www.liverpool.ac.uk/D3RE/PDE3. The database is reliable: 94% of the included drugs have corroborative evidence of efficacy in animal models (for example, evidence from multiple independent studies). The database includes many drugs that are appealing candidates for repurposing, as they are widely accepted by prescribers and patients-the database includes half of the 20 most commonly prescribed drugs in England-and they target many proteins involved in epilepsy but not targeted by current AEDs. It is important to note that the drugs are of potential relevance to human epilepsy-the database is highly enriched with drugs that target proteins of known causal human epilepsy genes (Fisher's exact test P-value < 3 × 10 ). We present data to help prioritize the most promising candidates for repurposing from the database.

SIGNIFICANCE

The PDE3 database is an important new resource for drug repurposing research in epilepsy.

摘要

目的

目前的抗癫痫药物(AEDs)存在几个缺点。例如,它们未能控制 30%的患者的癫痫发作。因此,有必要寻找新的 AEDs。药物再利用是指发现已批准药物的新用途。这种药物“回收”有潜力在药物开发的时间和成本方面带来重大节省。许多获得其他适应证许可的药物在动物模型中表现出抗癫痫疗效。我们的目的是创建一个数据库,其中包含已批准用于其他疾病的“可处方”药物,这些药物在癫痫动物模型中具有已发表的疗效证据,并整理有助于选择最有希望进行药物再利用的候选药物的数据。

方法

该数据库是通过以下方式创建的:(1)使用新颖的软件进行计算文献挖掘,该软件可识别包含可处方药物名称、啮齿动物癫痫模型和表示癫痫发作减少的短语的 Medline 摘要;然后(2)对识别出的摘要进行众包人工审核。

结果

最终数据库包含 173 种药物和 500 个摘要。它可在 www.liverpool.ac.uk/D3RE/PDE3 上免费获得。该数据库是可靠的:94%的纳入药物在动物模型中有疗效的佐证证据(例如,来自多个独立研究的证据)。该数据库包括许多作为再利用的有吸引力的候选药物,因为它们被处方医生和患者广泛接受——该数据库包括英格兰 20 种最常用药物中的一半——它们针对许多与癫痫有关但不受当前 AED 靶向的蛋白质。值得注意的是,这些药物与人类癫痫有关——该数据库高度富集了针对已知人类癫痫因果基因的蛋白质的药物(Fisher 精确检验 P 值<3×10 )。我们提供了数据,以帮助从数据库中确定最有希望进行再利用的候选药物。

意义

PDE3 数据库是癫痫药物再利用研究的一个重要新资源。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验